Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Reconstitute: Add 3.0 mL bacteriostatic water ~ 3.33 mg/mL total concentration (1.67 mg/mL each peptide)
Additionally, glutathione supplements have been shown to reduce inflammation and oxidative stress in the liver, further supporting its health
However, even younger individuals can use a peptide serum as a preventative measure to maintain healthy, resilient skin
10.1016/j.clon.2014.01.009 18 DongD.WuJ.ShengL.GongX.ZhangZ.YuC
US$ 25.84
US$ 21.75
